Investors aren't optimistic after an FDA advisory committee vote for avacopan.Shares of ChemoCentryx (NASDAQ: CCXI) were cratering by 58.3% as of 11:40 a.m. EDT on Friday. The stock also crashed on Tuesday after the U.S. Food and Drug Administration (FDA) released briefing documents for an advisory ...

https://www.fool.com/investing/2021/05/07/why-chemocentryx-stock-is-cratering-again-today/?source=iedfolrf0000001

#fool